Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huperzine A injection for cerebral function protection in cerebral infarction
ChiCTR2000034554Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Henan University
- Start
- Jul 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Huperzine A in brain infarction and ischemic stroke (2 arms), sponsored by The First Affiliated Hospital of Henan University. Primary endpoint: NIHSS score. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
Huperzine A
03
Conditions
brain infarctionischemic stroke
Beyond the preview
Go deeper on ChiCTR2000034554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034554.